Fig 1. Representative immunohistochemistry for ERG and PTEN in prostate cancer.
(A) ERG negative, (B) weak, (C) moderate, and (D) strong, and (E) PTEN negative, (F) weak, (G) moderate, and (H) strong, respectively. (x40).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.